Premji Invest adds another company to portfolio
Premji Invest, the family office of Wipro founder chairman Azim Premji and one of the most active private equity-style ......
Carlyle-backed Indegene makes another overseas acquisition
Indegene, a technology-led healthcare solutions provider to biopharmaceutical, biotech and medical devices companies, ......
Carlyle makes a partial exit from IPO-bound Indegene
Private equity firm Carlyle has trimmed its stake in Indegene, just two years after teaming up with another investment ......
Deals Digest: PE/VC volume stays strong but total value falls
Private equity (PE) and venture capital (VC) dealmaking activity remained high in terms of volume, but total transaction......
Weekly Deal Wrap: Meet chart-toppers Indegene, Teen Patti maker and Zetwerk
Technology as a theme dominated the deal charts in the first week of February as Indegene, Teen Patti developer Moonfrog Labs...
Deals Digest: PE/VC activity slows but M&A value jumps on a jumbo transaction
Private equity and venture capital investments fell during the five-day period ending Friday from the week before but ......
PE/VC firms cash in on stock market rally to mint $3 bn via exits within a month
Over a dozen private equity and venture capital firms took advantage of the stock market rally that pushed India’s......
Carlyle hires former Bain Capital exec to beef up India team
Private equity firm Carlyle Group Inc, which has had a busy 2025 so far in India with at least four exit moves and a ......
Deals Digest: PE/VC investment transactions flat as focus shifts to exits
The number of private equity and venture capital investment deals remained flat in the week ended Friday as alternative ......
Indegene close to buying two US health-tech firms
Bangalore-headquartered Indegene Lifesystems Pvt Ltd, which provides clinical, commercial and marketing solutions to global lifescience and pharmaceutical companies, is set to acquire two small firms in the healthcare technology space in US, its co-founder & CEO told VCCircle.“We continue to look at acquisitions in the healthcare and physician engagement. At ......














